Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL749P, officially named **RNA, 7SL, cytoplasmic 749, pseudogene**, is a **human pseudogene** derived from the 7SL RNA gene family. The 7SL RNA is the RNA component of the **signal recognition particle (SRP)**, a ribonucleoprotein complex responsible for directing proteins to the endoplasmic reticulum during translation, but pseudogenes like RN7SL749P are nonfunctional DNA segments that resemble functional 7SL RNA genes[1][4][6][7]. Most 7SL pseudogenes are **truncated, noncoding, and not expressed at the RNA or protein level**, having resulted from historical retrotransposition or duplication events in the genome[6][3]. There is no evidence that RN7SL749P exerts any physiological function, is involved in disease, or serves as a therapeutic target[7][4][6]. **Notes on target status and accuracy:** - RN7SL749P is a pseudogene, meaning it **does not code for a functional product** (neither RNA for SRP function nor protein)[4][3][6][7]. - Pseudogenes generally are **not considered drug targets, receptors, enzymes, or functional molecular entities**, and there are no known drugs or mechanisms of action involving RN7SL749P[2][4]. - Some pseudogenes can regulate their parental genes by acting as competing endogenous RNAs, but this is not described for RN7SL749P; thus, its clinical or functional relevance is unknown[2]. - The query is somewhat incorrect for treating RN7SL749P as a classical therapeutic target or receptor—it is a **nonfunctional pseudogene**, and there is no disease or biomarker role reported. **Summary for structured extraction:** RN7SL749P is a **pseudogene** of the 7SL RNA and **not a valid therapeutic target**. It **does not have biological, pathological, or pharmacological relevance**, and should not be treated as a classical drug target or receptor[4][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 749, pseudogene (RN7SL749P).